From: healthline.com While there’s no way to guarantee that breast cancer will never come back, medical oncologist Amy Tiersten, MD, shares how taking steps to stay healthy may also help prevent breast cancer recurrence. How important is it to stay active? Exercise has definitely been proven to reduce the risk of breast cancer recurrence. Exercising as little as 30 minutes …
Switch to Experimental Drug after Liquid Biopsy Detection of Breast Cancer Recurrence Improves Outcomes
From: cornell.edu A large prospective, randomized clinical trial in patients with advanced breast cancer has found that the use of liquid biopsy blood tests for early detection of a treatment-resistance mutation, followed by a switch to a new type of treatment, substantially extends the period of tumor control compared to standard care. The SERENA-6 study, published June 1 in the …
Interventions for Breast Cancer-Related Distress Focus on Patient and Spouse as Dyad Unit
By: Jennifer Larson From: oncologynurseadvisor.com The patient and their spouse should be deliberately considered as a closely knit unit. Essential information about the disease should be provided to both patients and their spouses to nurture positive perceptions. Interventions for psychological distress related to breast cancer need to address the patient and her spouse as a dyadic unit to promote cognitive …
The 4th of July – Independence Day for This Breast Cancer Survivor
View PostNew global study links red meat to rising breast cancer burden
By: Hugo Francisco de Souza From: news-medical.net In a recent study in the journal Frontiers in Public Health, researchers investigated temporal, geographic, and socio-demographic trends and risk associations in female breast cancer worldwide. Specifically, the study leveraged more than 30 years of data (1990–2021) from the Global Burden of Disease (GBD) 2021 study to quantify the impacts of high unprocessed …
Understanding BRCAness: What It Means for Cancer Treatment
By: Vijay Kumar Malesu From: news-medical.net Introduction BRCAness describes traits in certain tumors, particularly sporadic ovarian cancers, that mimic cancers associated with inherited mutations in breast cancer gene 1 (BRCA1) or BRCA2. Although BRCA mutations primarily affect hereditary cancers, some tumors without these mutations also exhibit similar molecular disruptions, a phenomenon referred to as ‘BRCAness.’ Understanding BRCAness is critical because …
Breast cancer tissue stiffness may affect immune system’s ability to fight tumors
By: University of Helsinki From: medicalxpress.com Although immunotherapy is among the most significant advances in cancer care, it is not effective in all patients. University of Helsinki researchers have provided new insights into why some breast cancer treatments may not be as effective for all patients. Published in Nature Communications, the findings provide a new direction for developing precision medicine. …
Three-time Cancer Survivor on a Mission to Uplift Others
From: cancer.org Standing at just 5 feet 1 inch tall, Carol Johnson-Cromer is a force of nature, radiating energy, resilience, and an unwavering commitment to lifting up others. A three-time breast cancer survivor, she was first diagnosed in 2000 at age 38 and faced breast cancer again in 2019 and 2023. Dealing with Cancer Diagnoses Her first encounter with cancer …
Visualization tool illuminates breast cancer cell migration, suggesting new treatment avenues
By: University of Turku From: medicalxpress.com Cancer cell movement during metastasis is a dynamic process regulated by several different signals. However, the way cells receive, process and respond to these signals has been extremely hard to detect, but is now made easier by a new visualization tool. In a new study published in Nature Cell Biology, led by Professor Johanna …
FDA Authorizes AI Platform for Breast Cancer Prediction
From: itnonline.com Clairity, Inc., a digital health innovator advancing AI-driven healthcare solutions, has received U.S. Food and Drug Administration (FDA) De Novo authorization for Clairity Breast, a novel, image-based prognostic platform designed to predict five-year breast cancer risk from a routine screening mammogram. With this authorization, Clairity is planning to launch among leading health systems through 2025 – propelling a new era …